Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Legal Finance topic
No spam. Unsubscribe anytime.
Commission approves eight opioid-settlement distributions including a $2,006,645 payment from Hikma
Summary
The board approved eight manufacturer-specific opioid settlements tied to Nevada's statewide agreement, including a $2,006,645.32 distribution from Hikma and smaller payments from manufacturers such as Mylan and Amneal.
County counsel Lincoln Sullivan explained that eight new settlement exhibits under Nevada's opioid agreement had reached their settlement amounts and were before the commission for approval. The exhibits listed per-manufacturer distributions ranging from hundreds of dollars up to multimillion-dollar figures; for example, the Hikma settlement was read as $2,006,645.32 and Mylan at $7,377.77.
Lincoln Sullivan said, "these are just 8 new settlements that were part of the Nevada agreement you guys signed into, and they, hadn't reached their settlement amounts, but now they have." The board moved to approve the listed settlements and recorded verbal "aye" votes. No further discussion was recorded in the transcript about allocation of proceeds or distribution timing; staff indicated these were formalities to recognize settlements that had now met payout thresholds.
The approvals covered amounts listed in the exhibits and were entered into the record for the county's participation in the broader Nevada opioid settlement process.
